{"entity":{"type":"insider","cik":"0001779614","url":"/insider/0001779614","json_url":"/insider/0001779614.json","name":"Lisicki Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":5,"first":"2019-11-26","last":"2021-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Lisicki Robert","source":"filing","n_filings":5,"first_seen":"2019-11-26","last_seen":"2021-08-05"}],"transactions":[{"id":5419263,"accession":"0001628280-21-015950","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-21-015950","line_url":"/filing/0001628280-21-015950","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001779614","owner_name":"Lisicki Robert","owner_display_name":"Lisicki Robert","owner_url":"/insider/0001779614","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":60.084697142857145,"price_display":"60.08","price_state":"stated","total_value":1051482.2,"total_display":"1,051,482.20","total_whole":"1,051,482","shares_owned_after":16101.0,"shares_owned_after_display":"16,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider","n_lines":2},{"id":5519451,"accession":"0001209191-21-007951","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-007951","line_url":"/filing/0001209191-21-007951","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001779614","owner_name":"Lisicki Robert","owner_display_name":"Lisicki Robert","owner_url":"/insider/0001779614","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":78.87476499428571,"price_display":"78.87","price_state":"stated","total_value":1380308.3874,"total_display":"1,380,308.39","total_whole":"1,380,308","shares_owned_after":9441.0,"shares_owned_after_display":"9,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider","n_lines":3},{"id":2884474,"accession":"0001209191-20-061450","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-061450","line_url":"/filing/0001209191-20-061450","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001779614","owner_name":"Lisicki Robert","owner_display_name":"Lisicki Robert","owner_url":"/insider/0001779614","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3872.0,"shares_display":"3,872","price_per_share":66.06040454545455,"price_display":"66.06","price_state":"stated","total_value":255785.8864,"total_display":"255,785.89","total_whole":"255,786","shares_owned_after":550.0,"shares_owned_after_display":"550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider","n_lines":3},{"id":2647205,"accession":"0001209191-20-045483","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-045483","line_url":"/filing/0001209191-20-045483","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001779614","owner_name":"Lisicki Robert","owner_display_name":"Lisicki Robert","owner_url":"/insider/0001779614","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":63.34484125,"price_display":"63.34","price_state":"stated","total_value":1900345.2375,"total_display":"1,900,345.24","total_whole":"1,900,345","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-04","filed_date":"2020-08-06","scope":"insider","n_lines":2},{"id":7885534,"accession":"0001209191-19-058166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058166","line_url":"/filing/0001209191-19-058166#line-1","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001779614","owner_name":"Lisicki Robert","owner_display_name":"Lisicki Robert","owner_url":"/insider/0001779614","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4429.0,"shares_display":"4,429","price_per_share":45.8342,"price_display":"45.83","price_state":"stated","total_value":202999.6718,"total_display":"202,999.67","total_whole":"203,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001080709","name":"ARENA PHARMACEUTICALS INC","url":"/issuer/0001080709","role":"Officer (EVP, Chief Commercial Officer)","n_filings":5,"first_seen":"2019-11-26","last_seen":"2021-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001779614","retrieved_at":"2026-08-24T18:01:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}